OOEP
geneOn this page
Also known as Em:AC019205.2KHDC2
Summary
OOEP (oocyte expressed protein, HGNC:21382) is a protein-coding gene on chromosome 6q13, encoding Oocyte-expressed protein homolog (A6NGQ2). Component of the subcortical maternal complex (SCMC), a multiprotein complex that plays a key role in early embryonic development.
Predicted to enable RNA binding activity. Predicted to be involved in several processes, including cytoskeleton organization; positive regulation of double-strand break repair via homologous recombination; and positive regulation of meiotic nuclear division. Predicted to act upstream of or within several processes, including embryo implantation; in utero embryonic development; and protein phosphorylation. Located in cytoplasm and nucleus. Part of subcortical maternal complex.
Source: NCBI Gene 441161 — RefSeq curated summary.
At a glance
- Gene–disease (curated): female infertility due to oocyte meiotic arrest (Moderate, GenCC)
- Clinical variants (ClinVar): 30 total
- MANE Select transcript:
NM_001080507
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21382 |
| Approved symbol | OOEP |
| Name | oocyte expressed protein |
| Location | 6q13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Em:AC019205.2, KHDC2 |
| Ensembl gene | ENSG00000203907 |
| Ensembl biotype | protein_coding |
| OMIM | 611689 |
| Entrez | 441161 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000370359, ENST00000370363, ENST00000441145
RefSeq mRNA: 2 — MANE Select: NM_001080507
NM_001080507, NM_001428256
CCDS: CCDS47451
Canonical transcript exons
ENST00000370359 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001452467 | 73369603 | 73369897 |
| ENSE00001452472 | 73368555 | 73368863 |
| ENSE00001547343 | 73369206 | 73369385 |
Expression profiles
Bgee: expression breadth ubiquitous, 127 present calls, max score 99.92.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8384 / max 42.9928, expressed in 277 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 74364 | 0.5821 | 247 |
| 74363 | 0.1737 | 84 |
| 74362 | 0.0761 | 30 |
| 204059 | 0.0065 | 3 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 99.92 | gold quality |
| secondary oocyte | CL:0000655 | 99.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.67 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.06 | gold quality |
| sperm | CL:0000019 | 82.91 | gold quality |
| left testis | UBERON:0004533 | 80.25 | gold quality |
| right testis | UBERON:0004534 | 80.19 | gold quality |
| testis | UBERON:0000473 | 79.78 | gold quality |
| tibialis anterior | UBERON:0001385 | 71.20 | silver quality |
| pancreatic ductal cell | CL:0002079 | 68.58 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 68.33 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 66.11 | gold quality |
| adult organism | UBERON:0007023 | 65.10 | gold quality |
| placenta | UBERON:0001987 | 62.78 | gold quality |
| cartilage tissue | UBERON:0002418 | 62.73 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 62.56 | gold quality |
| ileal mucosa | UBERON:0000331 | 62.41 | silver quality |
| amniotic fluid | UBERON:0000173 | 60.56 | gold quality |
| deltoid | UBERON:0001476 | 58.07 | gold quality |
| granulocyte | CL:0000094 | 57.46 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 56.73 | gold quality |
| myocardium | UBERON:0002349 | 56.11 | gold quality |
| parotid gland | UBERON:0001831 | 55.80 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 55.43 | gold quality |
| endothelial cell | CL:0000115 | 55.39 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 53.72 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 53.65 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-3929 | yes | 1043.15 |
| E-ANND-3 | no | 1.74 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
32 targeting OOEP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-497-5P | 99.92 | 71.83 | 2674 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-15A-5P | 99.90 | 72.80 | 2787 |
| HSA-MIR-15B-5P | 99.90 | 72.78 | 2798 |
| HSA-MIR-16-5P | 99.90 | 72.80 | 2780 |
| HSA-MIR-195-5P | 99.90 | 72.81 | 2805 |
| HSA-MIR-424-5P | 99.89 | 71.90 | 2641 |
| HSA-MIR-6838-5P | 99.89 | 71.94 | 2690 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-4524A-5P | 99.57 | 71.73 | 1193 |
| HSA-MIR-4524B-5P | 99.57 | 71.68 | 1195 |
| HSA-MIR-155-5P | 99.35 | 70.16 | 1509 |
| HSA-MIR-3611 | 98.76 | 68.76 | 1290 |
| HSA-MIR-374B-3P | 98.63 | 68.24 | 1360 |
| HSA-MIR-676-5P | 98.49 | 68.87 | 1492 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-595 | 98.25 | 67.44 | 699 |
| HSA-MIR-503-5P | 97.87 | 66.83 | 575 |
Literature-anchored findings (GeneRIF, showing 1)
- Mutations in OOEP and NLRP5 identified in infertile patients with early embryonic arrest. (PMID:35946397)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ooep | ENSMUSG00000032346 |
| rattus_norvegicus | Ooep | ENSRNOG00000025957 |
Paralogs (1): KHDC3L (ENSG00000203908)
Protein
Protein identifiers
Oocyte-expressed protein homolog — A6NGQ2 (reviewed: A6NGQ2)
Alternative names: KH homology domain-containing protein 2, Oocyte- and embryo-specific protein 19
All UniProt accessions (3): A6NGQ2, C9J915, F2Z364
UniProt curated annotations — full annotation on UniProt →
Function. Component of the subcortical maternal complex (SCMC), a multiprotein complex that plays a key role in early embryonic development. The SCMC complex is a structural constituent of cytoplasmic lattices, which consist in fibrous structures found in the cytoplasm of oocytes and preimplantation embryos. They are required to store maternal proteins critical for embryonic development, such as proteins that control epigenetic reprogramming of the preimplantation embryo, and prevent their degradation or activation. As part of the OOEP-KHDC3 scaffold, recruits BLM and TRIM25 to DNA replication forks, thereby promoting the ubiquitination of BLM by TRIM25, enhancing BLM retainment at replication forks and therefore promoting stalled replication fork restart. Positively regulates the homologous recombination-mediated DNA double-strand break (DSB) repair pathway by regulating ATM activation and RAD51 recruitment to DSBs in oocytes. Thereby contributes to oocyte survival and the resumption and completion of meiosis.
Subunit / interactions. Component of the subcortical maternal complex (SCMC), at least composed of NLRP5, KHDC3L, OOEP, and TLE6 isoform 1. Within the complex, interacts with NLRP5, KHDC3L and TLE6 isoform 1. As part of the SCMC interacts with the SCMC-associated protein NLRP4F. The SCMC may facilitate translocation of its components between the nuclear and cytoplasmic compartments. Forms a scaffold complex with KHDC3L/FILIA, and interacts with BLM and TRIM25 at DNA replication forks.
Subcellular location. Cytoplasm. Nucleus.
Domain organisation. Contains an atypical KH domain with amino acid changes at critical sites, suggesting that it may not bind RNA.
Similarity. Belongs to the KHDC1 family.
RefSeq proteins (2): NP_001073976, NP_001415185 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031952 | MOEP19_KH-like | Domain |
| IPR036612 | KH_dom_type_1_sf | Homologous_superfamily |
| IPR051778 | KHDC1 | Family |
Pfam: PF16005
UniProt features (18 total): strand 5, helix 4, sequence variant 4, chain 1, domain 1, turn 1, region of interest 1, mutagenesis site 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8X7V | ELECTRON MICROSCOPY | 3.01 |
| 8X7W | ELECTRON MICROSCOPY | 3.36 |
| 9L4L | ELECTRON MICROSCOPY | 3.4 |
| 9L4K | ELECTRON MICROSCOPY | 3.41 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NGQ2-F1 | 83.08 | 0.62 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 109–116 | impaired formation of the subcortical maternal complex (scmc). |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 106 (showing top):
GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY, GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR, GOBP_REGULATION_OF_DNA_RECOMBINATION, GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, GOBP_REGULATION_OF_NUCLEAR_DIVISION, GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION, GOBP_SPINDLE_LOCALIZATION, GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION, GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION, GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE, GOBP_REGULATION_OF_DNA_REPAIR, GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE, GOBP_ORGANELLE_FISSION, GOBP_EMBRYONIC_PATTERN_SPECIFICATION
GO Biological Process (12): actin filament organization (GO:0007015), embryonic pattern specification (GO:0009880), replication fork processing (GO:0031297), regulation of protein localization (GO:0032880), establishment or maintenance of apical/basal cell polarity (GO:0035088), positive regulation of meiotic nuclear division (GO:0045836), establishment of spindle localization (GO:0051293), regulation of cell division (GO:0051302), regulation of establishment of protein localization (GO:0070201), protein storage (GO:0140089), positive regulation of double-strand break repair via homologous recombination (GO:1905168), positive regulation of double-strand break repair (GO:2000781)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of cytoplasmic lattice (GO:0140094), protein binding (GO:0005515)
GO Cellular Component (6): nucleus (GO:0005634), cytoplasm (GO:0005737), cell cortex (GO:0005938), protein-containing complex (GO:0032991), subcortical maternal complex (GO:0106333), cytoplasmic lattice (GO:0140095)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| actin cytoskeleton organization | 1 |
| supramolecular fiber organization | 1 |
| pattern specification process | 1 |
| embryo development | 1 |
| DNA-templated DNA replication maintenance of fidelity | 1 |
| intracellular protein localization | 1 |
| regulation of localization | 1 |
| establishment or maintenance of bipolar cell polarity | 1 |
| regulation of meiotic nuclear division | 1 |
| positive regulation of meiotic cell cycle | 1 |
| positive regulation of nuclear division | 1 |
| positive regulation of cell cycle process | 1 |
| meiotic nuclear division | 1 |
| microtubule cytoskeleton organization | 1 |
| establishment of localization in cell | 1 |
| spindle localization | 1 |
| establishment of organelle localization | 1 |
| regulation of cellular process | 1 |
| cell division | 1 |
| regulation of protein localization | 1 |
| establishment of protein localization | 1 |
| nutrient storage | 1 |
| double-strand break repair via homologous recombination | 1 |
| regulation of double-strand break repair via homologous recombination | 1 |
| positive regulation of DNA recombination | 1 |
| positive regulation of double-strand break repair | 1 |
| double-strand break repair | 1 |
| positive regulation of DNA repair | 1 |
| regulation of double-strand break repair | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| cell periphery | 1 |
| cellular_component | 1 |
| protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
344 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OOEP | TLE6 | Q9H808 | 999 |
| OOEP | KHDC1 | Q4VXA5 | 974 |
| OOEP | PADI6 | Q6TGC4 | 965 |
| OOEP | NLRP5 | P59047 | 949 |
| OOEP | KHDC3L | Q587J8 | 830 |
| OOEP | NLRP2 | Q9NX02 | 779 |
| OOEP | ZBED3 | Q96IU2 | 735 |
| OOEP | NLRP7 | Q8WX94 | 629 |
| OOEP | ZAR1 | Q86SH2 | 609 |
| OOEP | PRR23E | Q8N813 | 477 |
| OOEP | DDX1 | Q92499 | 473 |
| OOEP | SEBOX | Q9HB31 | 459 |
| OOEP | SMCO3 | A2RU48 | 450 |
| OOEP | DPPA3 | Q6W0C5 | 447 |
| OOEP | PATL2 | C9JE40 | 430 |
IntAct
36 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ABI2 | OOEP | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | SNRPB | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | LONRF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | KIF9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | AIRIM | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | TCEANC | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | ALOX5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | ABI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | ENKD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OOEP | KHDC3L | psi-mi:“MI:0915”(physical association) | 0.460 |
| KHDC3L | OOEP | psi-mi:“MI:0915”(physical association) | 0.460 |
| KHDC3L | OOEP | psi-mi:“MI:0403”(colocalization) | 0.460 |
| NLRP5 | OOEP | psi-mi:“MI:0915”(physical association) | 0.400 |
| OOEP | TLE6 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TLE6 | OOEP | psi-mi:“MI:0915”(physical association) | 0.400 |
| OOEP | NLRP7 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SNRPB | OOEP | psi-mi:“MI:0915”(physical association) | 0.000 |
| LONRF1 | OOEP | psi-mi:“MI:0915”(physical association) | 0.000 |
| TCEANC | OOEP | psi-mi:“MI:0915”(physical association) | 0.000 |
| ALOX5 | OOEP | psi-mi:“MI:0915”(physical association) | 0.000 |
| NTAQ1 | OOEP | psi-mi:“MI:0915”(physical association) | 0.000 |
| KIF9 | OOEP | psi-mi:“MI:0915”(physical association) | 0.000 |
| AIRIM | OOEP | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Two-hybrid), OOEP (Affinity Capture-MS), OOEP (Positive Genetic)
ESM2 similar proteins: A0JNQ6, A6NC42, A6NGQ2, A6NGR9, A6QP75, A7E3N7, A9X185, E1BDF2, E9PGG2, F6SZT2, P0C7A0, P85965, Q06VW1, Q0ZFW8, Q14DK4, Q3UK37, Q3UV16, Q3ZBN4, Q400G9, Q4VXA5, Q587J8, Q5JSQ8, Q60953, Q60I26, Q60I27, Q6NUI2, Q6ZUX3, Q810I0, Q8BH06, Q8C0R7, Q8IWB1, Q8IWY9, Q8IYX4, Q8K4C2, Q8N6L0, Q8N7F7, Q8NCV1, Q8TE82, Q91WA6, Q95JV3
Diamond homologs: A0JNQ6, A6NC42, A6NGQ2, A9X185, Q06VW1, Q0ZFW8, Q9CWE6, F6SZT2, P85965, Q587J8, Q9CQS7, D3ZVV1, Q9CWU5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
347 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:73369656:AGTT:A | donor_gain | 0.9900 |
| 6:73369659:T:TA | donor_gain | 0.9900 |
| 6:73369719:CGCAG:C | donor_gain | 0.9900 |
| 6:73369257:TC:T | donor_gain | 0.9800 |
| 6:73369382:GGGCC:G | acceptor_gain | 0.9800 |
| 6:73369383:GGCCT:G | acceptor_gain | 0.9800 |
| 6:73369384:GCCT:G | acceptor_gain | 0.9800 |
| 6:73395104:G:GT | donor_gain | 0.9800 |
| 6:73368864:C:CC | acceptor_gain | 0.9700 |
| 6:73369174:T:TA | donor_gain | 0.9700 |
| 6:73369382:GGGC:G | acceptor_loss | 0.9700 |
| 6:73369383:GGCC:G | acceptor_loss | 0.9700 |
| 6:73369596:CGCT:C | donor_loss | 0.9700 |
| 6:73369597:GCTC:G | donor_loss | 0.9700 |
| 6:73369598:CTCAC:C | donor_loss | 0.9700 |
| 6:73369599:T:TA | donor_loss | 0.9700 |
| 6:73369602:C:CG | donor_loss | 0.9700 |
| 6:73369386:C:CC | acceptor_gain | 0.9600 |
| 6:73369601:A:AC | donor_gain | 0.9600 |
| 6:73369602:C:CC | donor_gain | 0.9600 |
| 6:73369626:G:A | donor_gain | 0.9600 |
| 6:73369673:C:CT | donor_gain | 0.9600 |
| 6:73394992:G:GT | donor_gain | 0.9600 |
| 6:73395050:G:GA | donor_gain | 0.9600 |
| 6:73368859:CTCAG:C | acceptor_gain | 0.9500 |
| 6:73368861:CAG:C | acceptor_gain | 0.9500 |
| 6:73369595:TCGC:T | donor_loss | 0.9500 |
| 6:73368940:T:TC | acceptor_gain | 0.9300 |
| 6:73369385:CCT:C | acceptor_gain | 0.9300 |
| 6:73369674:C:CT | donor_gain | 0.9300 |
AlphaMissense
960 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:73369675:A:G | W40R | 0.982 |
| 6:73369675:A:T | W40R | 0.982 |
| 6:73369670:A:C | F41L | 0.980 |
| 6:73369670:A:T | F41L | 0.980 |
| 6:73369672:A:G | F41L | 0.980 |
| 6:73369354:C:A | E74D | 0.973 |
| 6:73369354:C:G | E74D | 0.973 |
| 6:73369285:G:C | F97L | 0.972 |
| 6:73369285:G:T | F97L | 0.972 |
| 6:73369287:A:G | F97L | 0.972 |
| 6:73369289:A:T | V96D | 0.970 |
| 6:73369283:C:T | G98E | 0.967 |
| 6:73369671:A:G | F41S | 0.965 |
| 6:73369255:C:A | K107N | 0.963 |
| 6:73369255:C:G | K107N | 0.963 |
| 6:73369673:C:A | W40C | 0.957 |
| 6:73369673:C:G | W40C | 0.957 |
| 6:73369295:A:G | I94T | 0.951 |
| 6:73369295:A:C | I94S | 0.950 |
| 6:73369284:C:A | G98W | 0.945 |
| 6:73369671:A:C | F41C | 0.939 |
| 6:73369267:C:A | Q103H | 0.931 |
| 6:73369267:C:G | Q103H | 0.931 |
| 6:73369283:C:A | G98V | 0.924 |
| 6:73369301:A:T | V92D | 0.924 |
| 6:73369356:C:T | E74K | 0.924 |
| 6:73369295:A:T | I94N | 0.921 |
| 6:73369284:C:G | G98R | 0.909 |
| 6:73369284:C:T | G98R | 0.909 |
| 6:73369674:C:A | W40L | 0.908 |
dbSNP variants (sampled 300 via entrez): RS1000338324 (6:73369520 GAA>G), RS1000853553 (6:73370582 C>G), RS1000941999 (6:73370608 G>A), RS1001305732 (6:73370271 C>T), RS1001310409 (6:73370906 T>G), RS1001345995 (6:73371129 G>A), RS1001967508 (6:73371616 G>A,C), RS1002299478 (6:73371421 G>A), RS1003818984 (6:73368683 A>C), RS1003849804 (6:73371557 T>C), RS1004191157 (6:73369049 C>A,G), RS1005497008 (6:73369939 G>A,T), RS1006089036 (6:73371472 G>C), RS1008098116 (6:73368610 T>C), RS1008463394 (6:73368953 A>C)
Disease associations
OMIM: gene MIM:611689 | disease phenotypes: MIM:615774
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| female infertility due to oocyte meiotic arrest | Moderate | Autosomal recessive |
Mondo (2): inherited oocyte maturation defect (MONDO:0014769), female infertility due to oocyte meiotic arrest (MONDO:0044626)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| bisphenol S | increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: female infertility due to oocyte meiotic arrest
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): female infertility due to oocyte meiotic arrest, inherited oocyte maturation defect